Bristol Myers’ stock rallied Wednesday as investors maintained high hopes for Cobenfy as an Alzheimer’s treatment, even though the outcome of a late-stage trial has been delayed.
#delayed #clinical #trial #boosted #Bristol #Myers #Squibbs #stock #Heres
